ANMI inks deal for SPECT radiopharmaceutical
Advanced Nuclear Medicine Ingredients (ANMI) has signed an agreement to license...Read more on AuntMinnie.comRelated Reading:
Ga-68 PSMA-11 PET/MRI benefits prostate cancer patients
New SPECT tracer targets NSCLC receptor
Ga-68 PSMA-11 PET/MRI advances prostate cancer detection
Study warns of PSMA-PET imaging discrepancies
Gallium-labeled PET tracer could advance cancer detection
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Cancer | Cancer & Oncology | Non-Small Cell Lung Cancer | Nuclear Medicine | Prostate Cancer | Radiology | SPECT | Study